Sponsors
The organisers would like to thank the following companies for their support of EUROPE AF:
www.sjm.com
It is our mission to develop medical technology and services that put the most control possible into the hands of those who treat cardiac, neurological and chronic pain patients, worldwide. We do this because we are dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient
_new1.jpg)
www.AblationFrontiers.com
Ablation Frontiers is pioneering the treatment of arrhythmias by developing innovative, safe, and effective therapies. Our mission is to create unique, minimally-invasive technologies that simplify and shorten procedures. Our products will allow physicians in any hospital to treat all eligible patients and return them to healthier, happier lives.
www.cardima.com
Cardima is dedicated to the diagnosis and treatment of arrhythmias, focusing on AF. Cardima's linear ablation system includes the REVELATION® T-Flex, a deflectable multi-electrode device, and INTELLITEMP® Energy Management Device to deliver Controlled RF. Unique products include mapping microcatheters, the PATHFINDERS & fixed or deflectable guides.
_new2.jpg)
www.crbard.com
Bard Electrophysiology is a global company focused on the development and delivery of a broad range of devices for the diagnosis and treatment of cardiac arrhythmias. Bard EP offers the Electrophysiologist a product portfolio which includes advanced RF ablation and mapping catheters, diagnostic catheters, computer-based electrophysiology recording systems, temporary pacing electrodes, and vascular/cardiac access devices.
www.biosensewebster.com
Biosense Webster, a Johnson & Johnson company, is recognized worldwide as an industry leader in developing innovative solutions to cardiac arrhythmias. Guided by the needs of electrophysiologists and their patients, the company has pioneered innovative technology advancements ranging from the first deflectable tip catheter to the LASSO® 2515 Variable Circular Mapping Catheter to today’s most sophisticated three-dimensional cardiac mapping and navigation systems. Extensive experience, consistent focus and advanced technology continue to make Biosense Webster a global leader in the diagnosis and treatment of cardiac arrhythmias.
www.bostonscientific.com
Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 29,000 employees and revenue of $8.3 billion in 2007. For more than 25 years, Boston Scientific has advanced the practice of less-invasive medicine1 by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. The Company’s products help physicians and other medical professionals improve their patients’ quality of life by providing alternatives to surgery. For more information, please visit http://www.bostonscientific-international.com/home.bsci
1 Less-invasive medical technologies provide alternatives to major surgery and other medical procedures that are typically traumatic to the body. In less-invasive procedures, devices are usually inserted into the body through natural openings or small incisions and can be guided to most areas of the anatomy to diagnose and treat a wide range of medical problems.
_new2.jpg)
www.cryocath.com
CryoCath is a medical technology company that leads the world in developing catheter based cryotherapy products to treat cardiac arrhythmias. The new Arctic Front® balloon catheter designed to treat paroxysmal Atrial Fibrillation is currently available in Europe and in clinical trials in the United States.
www.hansenmedical.com
Hansen Medical develops and manufactures a new generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. The Sensei™ Robotic Catheter System and the Artisan™ Control Catheter allow physicians to instinctively navigate flexible catheters with greater stability and control during interventional procedures.
www.medtronic.com
Medtronic is the global leader in medical technology, focused on delivering leading edge diagnostics and therapies in the management of a broad spectrum of cardiac disorders including arrhythmias, structural heart and vascular diseases.
Visit our stand to find out more about our Electrophysiological and CRDM range of solutions for the accurate diagnosis, treatment and monitoring of arrhythmias.
An agreement between sanofi aventis and Bristol Myers-Squibb for the codevelopment and marketing of clopidogrel and irbesartan, two compounds from sanofi-aventis research.
Un accord entre sanofi-aventis et Bristol-Myers Sqibb pour le developpment et la commercialisation de clopidogrel et d'irbesartan, molecules issues de la recherche de sanofi-aventis.
www.sanofi-aventis.com
|